Skip to main content

Advertisement

Table 2 Patient characteristics

From: Early assessment of response to induction therapy in acute myeloid leukemia using 18F-FLT PET/CT

Patient no. Age Sex ECOG PS Risk status BM blasts (%) BM cellularity (%) WBC (× 109/L) Hb (g/dL) Platelet (× 109/L) LDH (U/L)
1 60 M 1 Poor 52 52 40.86 11.6 57 450
2 72 M 1 Indeterminate 30 30–40 3.23 4.7 27 378
3 40 F 1 Indeterminate 8 90 2.65 9.8 191 136
4 48 F 1 Indeterminate 33 80–90 2.1 7.2 112 124
5 66 M 0 Indeterminate 45 50 13.3 9.6 50 216
6 36 F 1 Favorable 21 80 17.34 7 10 571
7 73 M 2 Poor 39 100 19.02 4.6 10 606
8 19 M 1 Indeterminate 68 100 21.43 4.8 35 825
9 60 M 3 Favorable 25 80 30.72 3 11 706
10 55 M 2 Favorable 26 80 14.18 8.4 56 1144
  1. ECOG PS Eastern Cooperative Oncology Group performance status, Hb hemoglobin